Tectonic Therapeutic (TECX) Treasury Shares (2017 - 2026)
Tectonic Therapeutic (TECX) reported Treasury Shares of $479042.0 for Q1 2026, up 163.23% year-over-year from $181987.0 in Q1 2025, and up 82.71% quarter-over-quarter from $262184.0 in Q4 2025.
Tectonic Therapeutic (TECX) Treasury Shares (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 10 years of Treasury Shares data on file, last reported at $479042.0 in Q1 2026.
- Treasury Shares for Q1 2026 came in at $479042.0, up 163.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $479042.0 (up 163.23% YoY), and the FY2025 annual result was $262184.0, up 923.68% from the prior year.
- Treasury Shares climbed to $479042.0 in Q1 2026 per TECX's latest filing, from $262184.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $2.0 million in Q1 2023 and troughed at $6859.0 in Q3 2024.
- A 5-year average of $627190.4 and a median of $479042.0 in 2026 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2022 and 2024: Treasury Shares surged 87089.86% in 2022, then tumbled 99.44% in 2024.
- A 5-year view of Treasury Shares shows it stood at $940392.0 in 2022, then sank by 97.98% to $18968.0 in 2023, then jumped by 35.03% to $25612.0 in 2024, then surged by 923.68% to $262184.0 in 2025, then surged by 82.71% to $479042.0 in 2026.
- Business Quant data shows TECX's Treasury Shares at $479042.0 in Q1 2026, $262184.0 in Q4 2025, and $256325.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Tectonic Therapeutic | 528.16 Mn | 291.27 Mn | - | 479,042.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 479,042.00 |
| Mar 31, 2026 | 479,042.00 |
| Dec 31, 2025 | 262,184.00 |
| Dec 31, 2025 | 262,184.00 |
| Sep 30, 2025 | 256,325.00 |
| Sep 30, 2025 | 256,325.00 |
| Jun 30, 2025 | 193,628.00 |
| Jun 30, 2025 | 193,628.00 |
| Mar 31, 2025 | 181,987.00 |
| Mar 31, 2025 | 181,987.00 |
| Dec 31, 2024 | 25,612.00 |
| Dec 31, 2024 | 25,612.00 |
| Sep 30, 2024 | 6,859.00 |
| Sep 30, 2024 | 6,859.00 |
| Jun 30, 2024 | 11,447.00 |
| Jun 30, 2024 | 11,447.00 |
| Mar 31, 2024 | 677,785.00 |
| Mar 31, 2024 | 677,785.00 |
| Dec 31, 2023 | 18,968.00 |
| Dec 31, 2023 | 18,968.00 |